Discontinued — last reported Q3 '25
Non-Current Assets
Equity Method Investments
Labcorp Holdings Equity Method Investments decreased by 4.7% to $146.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 12.7%, from $168.00M to $146.60M. Over 5 years (FY 2020 to FY 2025), Equity Method Investments shows an upward trend with a 15.9% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ4 2014
Last reportedQ3 2025
How to read this metric
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
Detailed definition
These are investments in entities where the company exercises significant influence but does not have full control. The...
Peer comparison
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
Metric ID:
equity_method_investmentsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $82.10M | $62.10M | $60.90M | $62.20M | $57.70M | $63.70M | $65.70M | $65.80M | $67.20M | $39.50M | $26.90M | $17.70M | $17.50M | $16.90M | $16.30M | $168.00M | $160.40M | $168.20M | $153.90M | $146.60M |
| QoQ Change | — | -24.4% | -1.9% | +2.1% | -7.2% | +10.4% | +3.1% | +0.2% | +2.1% | -41.2% | -31.9% | -34.2% | -1.1% | -3.4% | -3.6% | +930.7% | -4.5% | +4.9% | -8.5% | -4.7% |
| YoY Change | — | — | — | — | -29.7% | +2.6% | +7.9% | +5.8% | +16.5% | -38.0% | -59.1% | -73.1% | -74.0% | -57.2% | -39.4% | +849.2% | +816.6% | +895.3% | +844.2% | -12.7% |
Range$16.30M – $168.20M
CAGR+13.0%
Avg YoY Growth+190.9%
Median YoY Growth-5.1%
Current Streak2 quarters decline
Equity Method Investments at Other Companies
Frequently Asked Questions
- What is Labcorp Holdings's equity method investments?
- Labcorp Holdings (LH) reported equity method investments of $146.60M in Q1 2026.
- How has Labcorp Holdings's equity method investments changed year-over-year?
- Labcorp Holdings's equity method investments decreased by 12.7% year-over-year, from $168.00M to $146.60M.
- What is the long-term trend for Labcorp Holdings's equity method investments?
- Over 5 years (2020 to 2025), Labcorp Holdings's equity method investments has grown at a 15.9% compound annual growth rate (CAGR), from $73.50M to $153.90M.
- What does equity method investments mean?
- The value of investments in other companies where the firm has significant influence but not total control.